Olanzapine, an antipsychotic agent, exhibits poor water solubility, dissolution and flow properties. Thus, the aim of the present study was to improve the solubility and dissolution rate of Olanzapine by preparing microspheres by spray drying technique using β-cyclodextrin. Olanzapine Microspheres containing different ratios of β-cyclodextrin were produced by spray drying using Propanol and water (50:50) as solvent system to enhance solubility and dissolution rate. The prepared formulations containing different ratios of drug and β-cyclodextrin were evaluated for solubility and in-vitro dissolution. The prepared formulations were characterized by DSC, FT-IR, XRD and SEM. Dissolution profile of the prepared spray dried microspheres was compared with its physical mixture and pure sample. Spray dried microspheres exhibited decreased crystallinity. The solubility of microspheres containing Olanzapine and β-cyclodextrin (1:3w/w) exhibited tenfold increases than the commercial Olanzapine and dissolution of same ratio microsphere showed 99 % release in 20 min. while same composition in physical mixture showed 37% release in 20 min. Consequently, from the above result it can be concluded that spray dried microspheres of Olanzapine is a useful technique to improve the solubility and dissolution of poor water soluble drug like Olanzapine.
INTRODUCTION
Olanzapine, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno- [2, 3b] , [1, 5] benzodiazepine is a potent antipsychotic agent. As a free base or its hydrochloride salt, olanzapine is an active ingredient of pharmaceutical preparations used in the treatment of disorders of the central nervous system. Olanzapine belong to class II category under the biopharmaceutical classification system (BCS), i.e., it is inherently highly permeable through biological membranes, but exhibits low aqueous solubility.
Rate of absorption and/or extent of bioavailability for such insoluble hydrophobic drug are controlled by rate of dissolution in gastro-intestinal fluids. However, its oral bioavailability is very low, probably due to poor solubility in water and insufficient dissolution rate (Aarsland et al., 1999; Adams and Mutasim, 1999; Almeida, 1998) . Consideration of the . modified Noyes-Whitney equation provides some hints about the dissolution rate of poorly soluble compounds might be improved to minimize the limitations to their oral availability. There have been numerous efforts to improve drug dissolution rates.
These include (a) reducing the particle size to increase the surface area; (b) using water-soluble carriers to form inclusion complexes; (c) solubilization in surfactant systems; (d) using prodrugs and drug derivatization; and (e) manipulation of the solid state of drug substances to improve the drug dissolution i.e. by reducing the crystallinity of drug substances through formation of solid dispersions.
However, there are practical limitations to these techniques (Shivakumar and James, 2001) . Although particle size reduction is commonly used to increase the dissolution rate, there is a practical limit to the size reduction that can be achieved by such commonly used methods as controlled crystallization and grinding. The use of very fine powders in a dosage form may also be problematic because of handling difficulties and poor wettability. Salt formation is not feasible for neutral compounds and the synthesis of appropriate salt forms of drugs which are weakly acidic or weakly basic may often not be practical.
Even when salts can be prepared, an increased dissolution rate in the gastrointestinal tract may not be achieved in many cases because of the reconversion of salts into aggregates of their respective acid or base forms.
The solubilization of drugs in organic solvents or in aqueous media by the use of surfactants and co-solvents leads to liquid formation that is usually undesirable from the viewpoints of patient acceptability and marketing (Christian and Jennifer, 2000) . Solid dispersions have been widely used to enhance the solubility, dissolution rate, and bioavailability of poorly soluble drugs (Anne et al., 2003; Abu, 1999; Sekiguchi and Obi, 1961; Win and Sidney, 1971) . There are different types solid dispersion systems categorized according to the physical states of the drug and the carrier in the systems. It may be a molecular solid solution, a dispersion of amorphous or crystalline drug particles in an amorphous carrier matrix, or a combination of a solution and dispersion of solids.
The enhancement in the dissolution rate is obtained by one or a combination of the following mechanisms: eutectic formation, increased surface area of the drug due to precipitation in the carrier, formation of true solid solution, improved wetability and drug precipitation as a metastable crystalline form or a decrease in substance crystallinity. The type of solid dispersion formed depends on both the carrier-drug combination and the method of manufacture.
Olanzapine was previously formulated as a solid dispersion in pre-gelatinized starch and sodium glycollate, obtaining a marked increase in aqueous solubility, dissolution rate and an improved drug release profile with respect to the pure drug (Venkateskumar, et al., 2011) .
The drug was also associated with hydrophilic polymers with the aim of improving the dissolution parameters in different formulations, such as freeze-dried tablets with micronized gelatin (Mudit et al., 2011) , controlled release tablets in the presence of methocel and ethocel (Amir et al.,2010) , long acting microspheres formed by different polylactic/polyglycolic acid (PLGA) co-polymers (Nahata and Saini, 2008) , or in the form of inclusion complexes with cyclodextrins (José et al, 2012; Ajit et al., 2012 ) and Lutrol solid dispersion (Adamo et al, 2010) .
Spray drying is one of the techniques of preparing solid dispersion and is widely used as an alternative to milling to reduce particle size (Michael et al., 2013; Amal and Ebtessam, 2005; Yuh-Fun et al., 2010) . The large surface area of the resulting particle should result in an enhanced solubility and dissolution rate, consequently, improved bioavailability. β-cyclodextrin are a family of compounds made up of sugar molecules bound together in a ring and contain 7-membered sugar ring molecule. Cyclodextrins are hydrophobic inside and hydrophilic outside, they can form complexes with hydrophobic compounds. Thus they can enhance the solubility and bioavailability of such compounds. The aim of the present study was to improve the solubility and dissolution rate of olanzapine by spray drying technique using different ratio of β-cyclodextrin.
MATERIALS AND METHODS

Materials
All chemicals and buffers used were of analytical grade.
Methods
Preparation of microspheres
The microspheres were prepared by spray-drying technique. The spray drying was performed by Mini Spray Dryer LSD -48; (Jay instrument & systems Pvt. Ltd. Mumbai). The different drug-polymer ratios used for various microsphere formulations were prepared described in Table 1 . The polymer solution was prepared by adding given quantity of polymer to the propanol as solvent. The given quantity of Olanzapine was added to the polymer solution and the resulting mixture was spray-dried. The spray drying parameters are described in Table 2 . 
Preparation of Physical Mixtures
The different drug-polymer ratios used for various physical mixtures formulations were prepared as described in Table 1 and were prepared by mixing different ratio of Olanzapine and β-cyclodextrin in the mortar for 5 min and then sieving.
Evaluation of Microspheres Determination of percentage yield and drug content
The percentage yield of each formulation was determined according to the total recoverable final weight of microspheres and the total original weight of Olanzapine and β-cyclodextrin.
Microspheres (50 mg) were triturated with 10 ml of water. Allowed to stand for 10 min with occasional swirling and methanol was added to produce 100 ml. After suitable dilution, samples were measured at 250 nm. Drug content was determined from standard plot.
Differential scanning calorimetry (DSC)
A DSC study was carried out to detect possible polymorphic transition during the crystallization process. DSC measurements were performed on a DSC DuPont 9900, differential scanning calorimeter with a thermal analyzer.
Fourier transform infrared spectroscopy (FTIR)
The FTIR spectral measurements were taken at ambient temperature using a Shimadzu, Model 8033 (USA). Samples were dispersed in KBr powder and the pellets were made by applying 5 ton pressure. FTIR spectra were obtained by powder diffuse reflectance on FTIR spectrophotometer.
X-ray diffraction analysis (XRD)
X-Ray powder diffraction patterns were obtained at room temperature using a Philips X' Pert MPD diffractometer, with Cu as anode material and graphite monochromator, operated at a voltage of 40 mA, 45 kV. The process parameters used were set as scan step size of 0.0170 (2).
Scanning electron microscopy (SEM)
Scanning electron microscopic (Joel-LV-5600, USA, with magnification of 250x) photographs were obtained to identify and confirm spherical nature and surface topography of the crystals.
Mechanical properties
Tensile strength of microspheres was determined by compressing 500 mg of crystals using hydraulic press at different ton/cm 2 for 1 min. The compacts were stored in desiccator overnight to allow elastic recovery. The thickness and diameter were measured for each compact. The hardness of each compact was then measured using Pfizer hardness tester. The tensile strength (σ) of the compact (ton/cm 2 ) was calculated using following equation. σ = 2F/π Dt Where, F, D and t are hardness (ton), compact diameter (cm) and thickness (cm), respectively.
Determination of solubility
Drug solubility was determined by adding excess amounts of pure Olanzapine, their physical mixture and microspheres in distilled water at 37 ± 0.5°C, respectively. The solution formed were equilibrated under continuous agitation for 24 h and passed through a 0.8 μm membrane filter to obtain a clear solution.
The absorbance of the samples was measured using UV spectrophotometer method (UV 1601 A Shimadzu, Japan) at 229 nm and the concentrations in μg/ml were determined. Each sample was determined in triplicate.
Dissolution studies of microspheres
The dissolution of pure Olanzapine, their physical mixture and microspheres was determined by using USP dissolution apparatus XXIV-Type II (Electro Lab, Mumbai). Dissolution medium was 900 ml of pH 7.4 phosphate buffer. The amount of dissolved drug was determined using UV spectrophotometer method (UV 1601 A Shimadzu, Japan) at 229 nm. Each sample was determined in triplicate.
Determination of the physical stability
To determine the physical stability of optimized Microspheres, a stability study of prepared Microspheres was carried out at 25°C and 60% relative humidity for 6 months according to the ICH guidelines. The spherical agglomerates were packed in high density polyethylene (HDPE) container and placed in stability chamber. The samples were withdrawn at the interval of 0, 1, 3 and 6 months and evaluated for appearance, characterization by FT-IR and dissolution release and compared with initial results.
RESULT AND DISCUSSION
Cyclodextrins (CDs) are cyclic oligosaccharides consisting of (α-1, 4)-linked α-D-glucopyranose units that contain a lipophilic internal cavity and a hydrophilic outer surface. The hydroxyl functions of the glucose are orientated to the exterior, which gives it hydrophilic character. The inner cavity is lined by skeletal carbons and ethereal oxygen's of the sugar residues, which gives it a lipophilic character. These characteristics favour CDs to form inclusion complexes with a variety of host-guest molecules of suitable polarity and size. This characteristic of cyclodextrin is used to improve the pharmaceutical properties of numerous drugs such solubility, dissolution, bioavailability and stability. (Kaneto et al., 1998; Martin, 2004; Rubén et al., 2010) .
The spray dried microspheres formulations were collected and were found to be free-flowing and white in color. The percentage yield of spray dried microspheres of different ratios of drug-polymer was found to be in the range of 65-84 %. This small yield could be increased by addition of solid substance or in large scale production. Drug content for the spray dried microspheres of different ratio of drug-polymer formulation was found to be in the range of 93-99 %±0.013 (Table-3 In DSC curve, pure celecoxib had a sharp endothermic peak at 160°C that corresponded to the melting point of Olanzapine. In the thermogram of β-cyclodextrin, a sharp peak (261.3°C) was observed, which was associated with the endothermic melting of β-cyclodextrin. In DSC spectra of physical mixture showed peaks at 257 to 261°C for Olanzapine. However, the melting endotherm was absent on the DSC thermogram for the Microspheres, suggesting absence of crystallinity and presence of an amorphous state of the drug. This could be because Olanzapine was molecularly or amorphously dispersed in the Microspheres.
The FTIR spectra of pure Olanzapine, β-cyclodextrin, their physical mixture and microspheres of different ratios are shown in Fig 2. FTIR spectroscopy has been successfully used for exploring the differences in molecular conformations, crystal packing and hydrogen bonding arrangements for different solidstate forms of an organic compound. Spectral variations originate due to alteration in bonds that exhibit characteristic vibrational frequencies, leading to frequency shifts and splitting in absorption peaks. The FTIR spectra of Olanzapine (Fig. 2) showed a characteristic peak for amino group of the ring containing two nitrogen atoms (3100-3400 cm−1). All the FTIR spectra's are showing similar peaks, hence its confirmed that both drug and polymer were comparable with each other. The characteristic peak of the olanzapine appeared in the 2θ range of 10-30o, thus indicating that the unprocessed Olanzapine was a crystalline material (José et al., 2012) . The pure drug exhibits its characteristic diffraction peaks at various diffraction angles, thus indicating the presence of crystallinity. The X-ray diffraction study of the drug and excipients PM showed the peak corresponding to the crystalline drug molecules present in the mixture, although their intensity was lower due to the high excipients-drug ratio employed. The diffraction pattern of the drug Microspheres showed absence, broadening and reduction of major Olanzapine diffraction peaks, thus indicating that the Microspheres contained mostly an amorphous form (disordered state). These results could explain the observed enhancement of solubility and rapid dissolution of Olanzapine in Microspheres. The SEM image of the pure drug, physical mixture and microspheres are shown in Fig. 4 . The Olanzapine particles in the physical mixture were broken into much smaller ones and irregular size (17-29 µm) and the shape of prepared microspheres are uniform and spherical in shape with small in size (8-16 µm) ( Table-3 ).The spherical shape of microspheres does not lead to cake formation during storage because of less point of contact thereby increasing the stability of the microsphere formulation, which is an advantage over other shapes. This could be therefore, indicate that Olanzapine particle size has been reduced, which also accelerates solubility and dissolution. Microspheres exhibited superior compressibility characteristics compared to physical mixture and pure sample of Olanzapine drug crystals (Fig. 5) . It could be due to the fact that during the process of compression fresh surfaces are formed by fracturing crystals. Surface freshly prepared by fracture enhanced the plastic inter particle bonding, resulting in a lower compression force required for compressing the microspheres under plastic deformation compared to that of single crystal. Tensile strength of the same ratio of microspheres and physical mixture (1:3) showed that tensile strength of microspheres higher than physical mixture as well as pure sample. This could be due to the increasing in the plastic inter particle bonding of microspheres. Increase in the solubility of Olanzapine from microspheres (0.188 mg/mL) was found to be nearly six times higher than the solubility of the pure drug (0.033 mg/mL), suggesting the presence of a high amount of an amorphous form of Olanzapine in the Microspheres, indicating super-saturation obtained from the SDT. Increase in the solubility of Olanzapine from the PM (0.064 mg/mL) was nearly two times higher than pure drug. This could be due to the solubilising effect of highly water-soluble β-cyclodextrin used in the formulation. The solubility results for the different formulations are shown in Table  3 . The higher solubility of Olanzapine from Microspheres may be due to the increased surface area, wettability and solubilising effect of highly water-soluble β-cyclodextrin used in the formulations.
The dissolution of pure Olanzapine, physical mixture and prepared microspheres in pH 7.4 phosphate buffer shown in Fig. 6 , the dissolution profiles were plotted as the % release from the different microspheres, physical mixture and pure Olanzapine versus time in minute. The rate of dissolution of pure Olanzapine was slow compared with Olanzapine from its physical mixtures and different microspheres formulation in 60 min. The % release from ratio of (1:3 w/w) drug and polymer showed more release compared to other ratios. In case of microspheres containing (1:3 w/w) showed 99% release in 20 min and at the same ratio of physical mixture showed 68% release in 60 min. There was a significant difference in the drug release between the microspheres and physical mixture. The increase in dissolution from the microspheres and physical mixtures was probably due to the wetting and solubilizing effect of the β-cyclodextrin, which could reduce the interfacial tension between the Olanzapine and the dissolution medium, thus leading to a higher dissolution rate then pure Olanzapine. The large surface area of the resulting microspheres should result in an enhanced dissolution rate and thereby improve the bioavailability.
The best way to guarantee stability is by maintaining their physical state and molecular structure. The results of the stability study of prepared microspheres (1:3 w/w) of Olanzapine stored at 25 0 C and 60% relative humidity for 6 month is presented in table 4. The influence of physical stability on the prepared crystals was investigated. Prepared microspheres of Olanzapine were stable and complied with all the properties when compared to initial results of prepared microspheres of Olanzapine. 
CONCLUSION
In this present study, an increased solubility and dissolution rate of olanzapine were achieved by preparing microspheres by spray drying technique using different ratio of β-cyclodextrin. DSC, FT-IR and XRD studies showed that there is no change in the crystal structure of olanzapine during the spray drying process and showed that spray dried microspheres exhibited decreased crystallinity. The solubility and dissolution of the spray dried microspheres was improved significantly compared with its physical mixture and pure sample of olanzapine. The olanzapine microspheres containing 1:3 w/w (olanzapine: β-cyclodextrin) showed highest % of drug release and solubility compare to other ratio, physical mixture and pure sample of olanzapine. Stability results showed that prepared microspheres stable for 6 month as per ICH guidelines. Hence, , from the above result it can be concluded that spray dried microspheres of Olanzapine is a useful technique to improve the solubility and dissolution of poorly water soluble drug like Olanzapine.
